

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.28025605 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.08143588 |
| 3 | macrophage activation involved in immune response (GO:0002281) | 4.93543431 |
| 4 | detection of external biotic stimulus (GO:0098581) | 4.61133404 |
| 5 | regulation of DNA endoreduplication (GO:0032875) | 4.49882968 |
| 6 | cellular extravasation (GO:0045123) | 4.49041690 |
| 7 | detection of other organism (GO:0098543) | 4.48141954 |
| 8 | mitotic sister chromatid cohesion (GO:0007064) | 4.35823991 |
| 9 | microglial cell activation (GO:0001774) | 4.34037857 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.31291427 |
| 11 | response to peptidoglycan (GO:0032494) | 4.29997344 |
| 12 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.28158174 |
| 13 | histone H3-K36 demethylation (GO:0070544) | 4.15386160 |
| 14 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.11103850 |
| 15 | histone H3-K4 trimethylation (GO:0080182) | 4.04840813 |
| 16 | macrophage activation (GO:0042116) | 4.03852265 |
| 17 | hepatocyte apoptotic process (GO:0097284) | 4.03245633 |
| 18 | nuclear pore complex assembly (GO:0051292) | 4.00445729 |
| 19 | detection of biotic stimulus (GO:0009595) | 3.97109686 |
| 20 | neutrophil activation (GO:0042119) | 3.93558921 |
| 21 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.91592878 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.83401060 |
| 23 | detection of bacterium (GO:0016045) | 3.80380566 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.65143472 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.65143472 |
| 26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63253304 |
| 27 | neutrophil mediated immunity (GO:0002446) | 3.59027815 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56616112 |
| 29 | nuclear pore organization (GO:0006999) | 3.53424023 |
| 30 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.50834958 |
| 31 | granulocyte activation (GO:0036230) | 3.48321562 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.47729159 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.42356345 |
| 34 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.36907344 |
| 35 | negative regulation of interleukin-12 production (GO:0032695) | 3.36771879 |
| 36 | myeloid cell activation involved in immune response (GO:0002275) | 3.36025238 |
| 37 | iron ion import (GO:0097286) | 3.34029790 |
| 38 | histone H3-K4 methylation (GO:0051568) | 3.32353646 |
| 39 | pore complex assembly (GO:0046931) | 3.31721789 |
| 40 | peptidyl-lysine trimethylation (GO:0018023) | 3.28265253 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.20312844 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15699598 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.15367315 |
| 44 | replicative senescence (GO:0090399) | 3.15234771 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.14801862 |
| 46 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.14440046 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.13638831 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13638831 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.13638831 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13638831 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13638831 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13638831 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13563654 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12161603 |
| 55 | interferon-gamma secretion (GO:0072643) | 3.11470849 |
| 56 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.06601212 |
| 57 | positive T cell selection (GO:0043368) | 3.04021050 |
| 58 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.00771426 |
| 59 | response to interleukin-15 (GO:0070672) | 2.99624754 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98957603 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98064517 |
| 62 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96327757 |
| 63 | histone H3-K9 demethylation (GO:0033169) | 2.95043893 |
| 64 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.93351077 |
| 65 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.93351077 |
| 66 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.93351077 |
| 67 | regulation of mast cell degranulation (GO:0043304) | 2.92802035 |
| 68 | histone mRNA catabolic process (GO:0071044) | 2.91742583 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90211672 |
| 70 | interkinetic nuclear migration (GO:0022027) | 2.89278973 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.88368826 |
| 72 | DNA strand renaturation (GO:0000733) | 2.87726609 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 2.86243019 |
| 74 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86161395 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.84743213 |
| 76 | germinal center formation (GO:0002467) | 2.84366097 |
| 77 | histone H3-K9 methylation (GO:0051567) | 2.83915019 |
| 78 | cellular response to ethanol (GO:0071361) | 2.81504695 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.79125580 |
| 80 | leukocyte aggregation (GO:0070486) | 2.79086019 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.78600016 |
| 82 | positive thymic T cell selection (GO:0045059) | 2.78116683 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77244696 |
| 84 | ganglion development (GO:0061548) | 2.76749070 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.76623835 |
| 86 | negative regulation of B cell proliferation (GO:0030889) | 2.76495835 |
| 87 | respiratory burst (GO:0045730) | 2.76483758 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75974756 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.75580771 |
| 90 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.75580771 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75227550 |
| 92 | B cell homeostasis (GO:0001782) | 2.74066357 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.73547731 |
| 94 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73166251 |
| 95 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73006700 |
| 96 | sister chromatid cohesion (GO:0007062) | 2.72005225 |
| 97 | regulation of necroptotic process (GO:0060544) | 2.71906882 |
| 98 | regulation of protein polyubiquitination (GO:1902914) | 2.70607023 |
| 99 | prostate gland growth (GO:0060736) | 2.70462718 |
| 100 | histone lysine methylation (GO:0034968) | 2.69265102 |
| 101 | interferon-gamma production (GO:0032609) | 2.68761179 |
| 102 | histone lysine demethylation (GO:0070076) | 2.67022136 |
| 103 | regulation of mast cell activation (GO:0033003) | 2.65859371 |
| 104 | regulation of regulated secretory pathway (GO:1903305) | 2.65821190 |
| 105 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64977362 |
| 106 | early endosome to late endosome transport (GO:0045022) | 2.64052387 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63997530 |
| 108 | immunoglobulin mediated immune response (GO:0016064) | 2.63853530 |
| 109 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.62562728 |
| 110 | embryonic process involved in female pregnancy (GO:0060136) | 2.62194694 |
| 111 | hypotonic response (GO:0006971) | 2.61473774 |
| 112 | cytokine secretion (GO:0050663) | 2.60796332 |
| 113 | regulation of macrophage cytokine production (GO:0010935) | 2.59880691 |
| 114 | leukocyte degranulation (GO:0043299) | 2.59699775 |
| 115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.59588216 |
| 116 | regulation of germinal center formation (GO:0002634) | 2.58600138 |
| 117 | histone demethylation (GO:0016577) | 2.58202554 |
| 118 | T-helper 1 type immune response (GO:0042088) | 2.57906961 |
| 119 | positive regulation of leukocyte degranulation (GO:0043302) | 2.57576324 |
| 120 | kinetochore organization (GO:0051383) | 2.55480214 |
| 121 | B cell proliferation (GO:0042100) | 2.54826769 |
| 122 | megakaryocyte development (GO:0035855) | 2.54146996 |
| 123 | negative regulation of T cell mediated immunity (GO:0002710) | 2.53900757 |
| 124 | regulation of DNA-dependent DNA replication (GO:0090329) | 2.53442044 |
| 125 | myeloid leukocyte activation (GO:0002274) | 2.52921289 |
| 126 | regulation of platelet aggregation (GO:0090330) | 2.52747584 |
| 127 | histone H3-K9 modification (GO:0061647) | 2.52495848 |
| 128 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.50328986 |
| 129 | cellular response to interleukin-15 (GO:0071350) | 2.50268915 |
| 130 | negative regulation of mast cell activation (GO:0033004) | 2.49358411 |
| 131 | meiotic chromosome segregation (GO:0045132) | 2.48795986 |
| 132 | response to host immune response (GO:0052572) | 2.47473793 |
| 133 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.47473793 |
| 134 | fibroblast migration (GO:0010761) | 2.43403942 |
| 135 | I-kappaB phosphorylation (GO:0007252) | 2.41013245 |
| 136 | regulation of histone H3-K27 methylation (GO:0061085) | 2.39504147 |
| 137 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.38961762 |
| 138 | response to host (GO:0075136) | 2.33897917 |
| 139 | response to host defenses (GO:0052200) | 2.33897917 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.33897917 |
| 141 | peptidyl-lysine methylation (GO:0018022) | 2.33347328 |
| 142 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.32101952 |
| 143 | microtubule anchoring (GO:0034453) | 2.31909409 |
| 144 | definitive hemopoiesis (GO:0060216) | 2.31736158 |
| 145 | neural tube formation (GO:0001841) | 2.30858630 |
| 146 | detection of molecule of bacterial origin (GO:0032490) | 2.30423146 |
| 147 | NIK/NF-kappaB signaling (GO:0038061) | 2.30294604 |
| 148 | regulation of granulocyte differentiation (GO:0030852) | 2.29082583 |
| 149 | modulation by symbiont of host cellular process (GO:0044068) | 2.28258041 |
| 150 | regulation of helicase activity (GO:0051095) | 2.28055135 |
| 151 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.27674295 |
| 152 | positive regulation of granulocyte differentiation (GO:0030854) | 2.26001683 |
| 153 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.23793215 |
| 154 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.23109554 |
| 155 | positive regulation of NIK/NF-kappaB signaling (GO:1901224) | 2.22947008 |
| 156 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.22897793 |
| 157 | protein dealkylation (GO:0008214) | 2.22750490 |
| 158 | protein demethylation (GO:0006482) | 2.22750490 |
| 159 | regulation of telomere maintenance (GO:0032204) | 2.22651910 |
| 160 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.21265184 |
| 161 | RNA-dependent DNA replication (GO:0006278) | 2.18757594 |
| 162 | N-terminal protein amino acid acetylation (GO:0006474) | 2.18127332 |
| 163 | dosage compensation (GO:0007549) | 2.17959797 |
| 164 | dendritic cell migration (GO:0036336) | 2.16749160 |
| 165 | protein localization to microtubule cytoskeleton (GO:0072698) | 2.16446903 |
| 166 | positive regulation of mRNA catabolic process (GO:0061014) | 2.15909212 |
| 167 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.15785697 |
| 168 | T-helper cell differentiation (GO:0042093) | 2.15785697 |
| 169 | kinetochore assembly (GO:0051382) | 2.15509688 |
| 170 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.14875560 |
| 171 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.14875560 |
| 172 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.14875560 |
| 173 | telomere maintenance via telomerase (GO:0007004) | 2.13763151 |
| 174 | DNA synthesis involved in DNA repair (GO:0000731) | 2.13719733 |
| 175 | smooth muscle tissue development (GO:0048745) | 2.12519879 |
| 176 | response to X-ray (GO:0010165) | 2.11927463 |
| 177 | DNA damage induced protein phosphorylation (GO:0006975) | 2.10717023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.70425375 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.30927663 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.27269383 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.25991912 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.16621233 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.02976901 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96844934 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91872369 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.80494495 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.69344697 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.69028180 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68198377 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.51297903 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.45273456 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29836304 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27621665 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.22962932 |
| 18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.21140629 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.20264484 |
| 20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.16249945 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05826401 |
| 22 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.04083832 |
| 23 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.03415382 |
| 24 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.00150291 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97986893 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.97778946 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96972415 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87014323 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86868059 |
| 30 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.84169074 |
| 31 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.84025842 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82876025 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81697615 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.81041544 |
| 35 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.77592394 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77157112 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.76516164 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.72476011 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72269152 |
| 40 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71834316 |
| 41 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.71392832 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66642161 |
| 43 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.66497268 |
| 44 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.62496723 |
| 45 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.60381597 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.58820096 |
| 47 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57057385 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56551151 |
| 49 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55595795 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54825798 |
| 51 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.54423287 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54309206 |
| 53 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52990273 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52788465 |
| 55 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.52215472 |
| 56 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51547740 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51448140 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50869720 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49730934 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48652012 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.47894382 |
| 62 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.47689175 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47291212 |
| 64 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44677663 |
| 65 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.44209059 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43289572 |
| 67 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42584914 |
| 68 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.42345972 |
| 69 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42315791 |
| 70 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.42236480 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41228082 |
| 72 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39461429 |
| 73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39069740 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.37430864 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.37426853 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37266791 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36854106 |
| 78 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35556481 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.35005331 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34882224 |
| 81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33703831 |
| 82 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.32762901 |
| 83 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.32267899 |
| 84 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.32117316 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31765361 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.31082298 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.30630818 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.29766728 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28775035 |
| 90 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.27228400 |
| 91 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26824325 |
| 92 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.26578414 |
| 93 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25451401 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25169114 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24823276 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.24504554 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23747283 |
| 98 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.23664245 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23356846 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23168336 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22968083 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22655524 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22655524 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.22354843 |
| 105 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.21843326 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21632432 |
| 107 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21334952 |
| 108 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20964606 |
| 109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20752862 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20095262 |
| 111 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.19444635 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17434279 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16750198 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16459044 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16252708 |
| 116 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15338398 |
| 117 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.15011401 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14322666 |
| 119 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.14081818 |
| 120 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12896182 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12328246 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11968653 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11600284 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11451409 |
| 125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11121938 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09364223 |
| 127 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09270991 |
| 128 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09151859 |
| 129 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08905021 |
| 130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07501022 |
| 131 | * KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.07490289 |
| 132 | MAF_26560356_Chip-Seq_TH1_Human | 1.07454343 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06829856 |
| 134 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06785597 |
| 135 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.06751391 |
| 136 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06291828 |
| 137 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06291828 |
| 138 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.05130398 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03831664 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03831664 |
| 141 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03711662 |
| 142 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01658204 |
| 143 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01550825 |
| 144 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01509546 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01029753 |
| 146 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00297191 |
| 147 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99727323 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99546922 |
| 149 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99154712 |
| 150 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98698490 |
| 151 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98153731 |
| 152 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98107261 |
| 153 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97282829 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96966193 |
| 155 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96199935 |
| 156 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95780317 |
| 157 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93907583 |
| 158 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92543273 |
| 159 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92348260 |
| 160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91125371 |
| 161 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87626356 |
| 162 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87428180 |
| 163 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86339905 |
| 164 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83489368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.41570352 |
| 2 | MP0003724_increased_susceptibility_to | 3.98843534 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 3.60153490 |
| 4 | MP0001188_hyperpigmentation | 2.96667445 |
| 5 | MP0003303_peritoneal_inflammation | 2.70896875 |
| 6 | MP0003787_abnormal_imprinting | 2.64865821 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.62251669 |
| 8 | MP0002009_preneoplasia | 2.55941567 |
| 9 | MP0003436_decreased_susceptibility_to | 2.53421918 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.52910359 |
| 11 | MP0000015_abnormal_ear_pigmentation | 2.47289086 |
| 12 | MP0005451_abnormal_body_composition | 2.43954304 |
| 13 | MP0000566_synostosis | 2.12490136 |
| 14 | MP0009697_abnormal_copulation | 2.11082979 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.05969729 |
| 16 | MP0002006_tumorigenesis | 2.04637037 |
| 17 | MP0004381_abnormal_hair_follicle | 2.01263427 |
| 18 | MP0005174_abnormal_tail_pigmentation | 2.00779119 |
| 19 | MP0003941_abnormal_skin_development | 1.98275897 |
| 20 | MP0005464_abnormal_platelet_physiology | 1.97389970 |
| 21 | MP0010307_abnormal_tumor_latency | 1.94589023 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.92347387 |
| 23 | MP0009785_altered_susceptibility_to | 1.88792178 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.88326245 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 1.86044204 |
| 26 | MP0005025_abnormal_response_to | 1.85496053 |
| 27 | MP0004883_abnormal_blood_vessel | 1.82549423 |
| 28 | MP0000685_abnormal_immune_system | 1.82132318 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 1.81481218 |
| 30 | MP0005171_absent_coat_pigmentation | 1.79422332 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.76409609 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.69469061 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.66569062 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.64088700 |
| 35 | MP0008058_abnormal_DNA_repair | 1.63420324 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.63397537 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.62117283 |
| 38 | MP0005248_abnormal_Harderian_gland | 1.59708154 |
| 39 | MP0000371_diluted_coat_color | 1.59597254 |
| 40 | MP0004947_skin_inflammation | 1.57535818 |
| 41 | MP0005310_abnormal_salivary_gland | 1.57052280 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.55123359 |
| 43 | MP0003121_genomic_imprinting | 1.53259733 |
| 44 | MP0003045_fibrosis | 1.51372720 |
| 45 | MP0000427_abnormal_hair_cycle | 1.50553530 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.48238782 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.45385642 |
| 48 | MP0005164_abnormal_response_to | 1.41803811 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.41770996 |
| 50 | MP0002095_abnormal_skin_pigmentation | 1.40893404 |
| 51 | MP0006082_CNS_inflammation | 1.40671358 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.39879681 |
| 53 | MP0002132_abnormal_respiratory_system | 1.39413392 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.38604572 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.36722710 |
| 56 | MP0000383_abnormal_hair_follicle | 1.36363760 |
| 57 | MP0003252_abnormal_bile_duct | 1.36184572 |
| 58 | MP0008057_abnormal_DNA_replication | 1.32600346 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.31224393 |
| 60 | MP0003890_abnormal_embryonic-extraembry | 1.31115987 |
| 61 | MP0002405_respiratory_system_inflammati | 1.29114512 |
| 62 | MP0001186_pigmentation_phenotype | 1.27019971 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.26196313 |
| 64 | MP0005503_abnormal_tendon_morphology | 1.22185667 |
| 65 | MP0006054_spinal_hemorrhage | 1.21531144 |
| 66 | MP0003866_abnormal_defecation | 1.21450219 |
| 67 | MP0008007_abnormal_cellular_replicative | 1.21367858 |
| 68 | MP0001851_eye_inflammation | 1.20986283 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.20475842 |
| 70 | MP0005671_abnormal_response_to | 1.18466421 |
| 71 | MP0000490_abnormal_crypts_of | 1.17893520 |
| 72 | MP0001800_abnormal_humoral_immune | 1.17384620 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.17055788 |
| 74 | MP0005409_darkened_coat_color | 1.16864135 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.16624636 |
| 76 | MP0002722_abnormal_immune_system | 1.15449606 |
| 77 | MP0001790_abnormal_immune_system | 1.14178901 |
| 78 | MP0005387_immune_system_phenotype | 1.14178901 |
| 79 | MP0008004_abnormal_stomach_pH | 1.12202300 |
| 80 | MP0002075_abnormal_coat/hair_pigmentati | 1.12123019 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.11694624 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.11694624 |
| 83 | MP0002928_abnormal_bile_duct | 1.11067133 |
| 84 | MP0002177_abnormal_outer_ear | 1.08998067 |
| 85 | MP0000767_abnormal_smooth_muscle | 1.06186844 |
| 86 | MP0002452_abnormal_antigen_presenting | 1.06088541 |
| 87 | MP0004484_altered_response_of | 1.05953675 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04612616 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 1.03901018 |
| 90 | MP0003091_abnormal_cell_migration | 1.03860514 |
| 91 | MP0002429_abnormal_blood_cell | 1.03781866 |
| 92 | MP0003943_abnormal_hepatobiliary_system | 1.01876242 |
| 93 | MP0004134_abnormal_chest_morphology | 0.96957538 |
| 94 | MP0002398_abnormal_bone_marrow | 0.95789789 |
| 95 | MP0001915_intracranial_hemorrhage | 0.94187772 |
| 96 | MP0003690_abnormal_glial_cell | 0.94077138 |
| 97 | MP0002796_impaired_skin_barrier | 0.93115717 |
| 98 | MP0002419_abnormal_innate_immunity | 0.92932840 |
| 99 | MP0003077_abnormal_cell_cycle | 0.92799135 |
| 100 | MP0001177_atelectasis | 0.91903433 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.90511960 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.89845095 |
| 103 | MP0001819_abnormal_immune_cell | 0.89456139 |
| 104 | MP0001119_abnormal_female_reproductive | 0.88842077 |
| 105 | MP0000858_altered_metastatic_potential | 0.88655708 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.88375791 |
| 107 | MP0002420_abnormal_adaptive_immunity | 0.88283183 |
| 108 | MP0000733_abnormal_muscle_development | 0.88249490 |
| 109 | MP0002168_other_aberrant_phenotype | 0.88009122 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.87856877 |
| 111 | MP0002723_abnormal_immune_serum | 0.87527193 |
| 112 | MP0003937_abnormal_limbs/digits/tail_de | 0.86838534 |
| 113 | MP0008469_abnormal_protein_level | 0.86454540 |
| 114 | MP0002998_abnormal_bone_remodeling | 0.86348753 |
| 115 | MP0003935_abnormal_craniofacial_develop | 0.86233890 |
| 116 | MP0002109_abnormal_limb_morphology | 0.86006243 |
| 117 | MP0001873_stomach_inflammation | 0.85905582 |
| 118 | MP0002060_abnormal_skin_morphology | 0.85532086 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.84698861 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.84209413 |
| 121 | MP0001853_heart_inflammation | 0.83078366 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.82749545 |
| 123 | MP0001293_anophthalmia | 0.82395962 |
| 124 | MP0003075_altered_response_to | 0.81205663 |
| 125 | MP0005408_hypopigmentation | 0.79437887 |
| 126 | MP0009115_abnormal_fat_cell | 0.78280045 |
| 127 | MP0002277_abnormal_respiratory_mucosa | 0.78231561 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 0.77524037 |
| 129 | MP0000516_abnormal_urinary_system | 0.77524037 |
| 130 | MP0000432_abnormal_head_morphology | 0.77185359 |
| 131 | MP0005166_decreased_susceptibility_to | 0.77106535 |
| 132 | MP0009764_decreased_sensitivity_to | 0.76346755 |
| 133 | MP0003828_pulmonary_edema | 0.75321525 |
| 134 | MP0008877_abnormal_DNA_methylation | 0.73685058 |
| 135 | MP0009703_decreased_birth_body | 0.73621969 |
| 136 | MP0000716_abnormal_immune_system | 0.73272489 |
| 137 | MP0001299_abnormal_eye_distance/ | 0.71556380 |
| 138 | MP0004185_abnormal_adipocyte_glucose | 0.71537707 |
| 139 | MP0003448_altered_tumor_morphology | 0.70993426 |
| 140 | MP0005275_abnormal_skin_tensile | 0.70941968 |
| 141 | MP0001191_abnormal_skin_condition | 0.70670899 |
| 142 | MP0008260_abnormal_autophagy | 0.70605391 |
| 143 | MP0010386_abnormal_urinary_bladder | 0.70521590 |
| 144 | MP0009333_abnormal_splenocyte_physiolog | 0.69989023 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.69435193 |
| 146 | MP0000627_abnormal_mammary_gland | 0.69285449 |
| 147 | MP0000609_abnormal_liver_physiology | 0.68279319 |
| 148 | MP0004510_myositis | 0.68176608 |
| 149 | MP0006292_abnormal_olfactory_placode | 0.67756864 |
| 150 | MP0003566_abnormal_cell_adhesion | 0.67202800 |
| 151 | MP0001175_abnormal_lung_morphology | 0.66896752 |
| 152 | MP0003705_abnormal_hypodermis_morpholog | 0.66702945 |
| 153 | MP0004130_abnormal_muscle_cell | 0.65331481 |
| 154 | MP0005621_abnormal_cell_physiology | 0.64441638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.41458712 |
| 2 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.17930220 |
| 3 | Chromsome breakage (HP:0040012) | 4.05826132 |
| 4 | Abnormality of the fingertips (HP:0001211) | 4.05759012 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.94587367 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.94211594 |
| 7 | Prostate neoplasm (HP:0100787) | 3.68343920 |
| 8 | Gingival bleeding (HP:0000225) | 3.49713631 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.40097761 |
| 10 | Recurrent skin infections (HP:0001581) | 3.21892101 |
| 11 | Lip pit (HP:0100267) | 3.19058478 |
| 12 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.18289434 |
| 13 | Abnormality of the nasal septum (HP:0000419) | 2.97341909 |
| 14 | Testicular neoplasm (HP:0010788) | 2.92805269 |
| 15 | Spontaneous hematomas (HP:0007420) | 2.89951186 |
| 16 | Keratoconjunctivitis (HP:0001096) | 2.86227816 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.80450881 |
| 18 | Prolonged bleeding time (HP:0003010) | 2.80401742 |
| 19 | Optic neuritis (HP:0100653) | 2.76235126 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 2.76235126 |
| 21 | Protruding tongue (HP:0010808) | 2.74561298 |
| 22 | Acute myeloid leukemia (HP:0004808) | 2.74207357 |
| 23 | Stomatitis (HP:0010280) | 2.72634834 |
| 24 | Peritonitis (HP:0002586) | 2.72320097 |
| 25 | Volvulus (HP:0002580) | 2.65387384 |
| 26 | Asymmetry of the thorax (HP:0001555) | 2.64819811 |
| 27 | Deep philtrum (HP:0002002) | 2.64815155 |
| 28 | Meningitis (HP:0001287) | 2.64287294 |
| 29 | Mesomelia (HP:0003027) | 2.62652970 |
| 30 | Slow saccadic eye movements (HP:0000514) | 2.61833192 |
| 31 | Vasculitis (HP:0002633) | 2.61386254 |
| 32 | Generalized hypopigmentation of hair (HP:0011358) | 2.54547944 |
| 33 | Viral hepatitis (HP:0006562) | 2.53821929 |
| 34 | Abnormality of chromosome stability (HP:0003220) | 2.53416813 |
| 35 | Chest pain (HP:0100749) | 2.48020678 |
| 36 | Neoplasm of the adrenal cortex (HP:0100641) | 2.46167325 |
| 37 | Bell-shaped thorax (HP:0001591) | 2.45194172 |
| 38 | Epistaxis (HP:0000421) | 2.44039514 |
| 39 | Fair hair (HP:0002286) | 2.43041745 |
| 40 | Urticaria (HP:0001025) | 2.39381140 |
| 41 | Thyroid carcinoma (HP:0002890) | 2.36867895 |
| 42 | Abnormality of incisor morphology (HP:0011063) | 2.36683405 |
| 43 | Micronodular cirrhosis (HP:0001413) | 2.35774556 |
| 44 | Syringomyelia (HP:0003396) | 2.35542040 |
| 45 | Spinal cord lesions (HP:0100561) | 2.35542040 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.34291204 |
| 47 | Absent frontal sinuses (HP:0002688) | 2.33764510 |
| 48 | Long eyelashes (HP:0000527) | 2.32344303 |
| 49 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.30894836 |
| 50 | Alveolar cell carcinoma (HP:0006519) | 2.30284263 |
| 51 | Curly hair (HP:0002212) | 2.29938246 |
| 52 | Hemoptysis (HP:0002105) | 2.29708208 |
| 53 | Pulmonary embolism (HP:0002204) | 2.27953651 |
| 54 | Ectopic kidney (HP:0000086) | 2.27912250 |
| 55 | Osteomyelitis (HP:0002754) | 2.26898826 |
| 56 | Encephalitis (HP:0002383) | 2.24426145 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.23330856 |
| 58 | Obstructive lung disease (HP:0006536) | 2.22435533 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22435533 |
| 60 | Gangrene (HP:0100758) | 2.22396501 |
| 61 | Renal cortical cysts (HP:0000803) | 2.21794226 |
| 62 | Amyloidosis (HP:0011034) | 2.20788525 |
| 63 | Abnormality of DNA repair (HP:0003254) | 2.20575861 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.19031636 |
| 65 | Episodic fever (HP:0001954) | 2.18381299 |
| 66 | T lymphocytopenia (HP:0005403) | 2.17947884 |
| 67 | Resting tremor (HP:0002322) | 2.16430449 |
| 68 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.13743915 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.12152127 |
| 70 | Cellulitis (HP:0100658) | 2.11640800 |
| 71 | Orchitis (HP:0100796) | 2.10955696 |
| 72 | Increased IgE level (HP:0003212) | 2.08939114 |
| 73 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.08643393 |
| 74 | Febrile seizures (HP:0002373) | 2.06030746 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.05696184 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.05345121 |
| 77 | Abnormality of the peritoneum (HP:0002585) | 2.05180867 |
| 78 | Truncal obesity (HP:0001956) | 2.04619074 |
| 79 | Midline defect of the nose (HP:0004122) | 2.03108552 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02947495 |
| 81 | Abnormality of the right ventricle (HP:0001707) | 2.02525571 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.02186676 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.02186676 |
| 84 | Abnormality of the preputium (HP:0100587) | 2.01967324 |
| 85 | Abnormal platelet volume (HP:0011876) | 1.99637406 |
| 86 | Stomach cancer (HP:0012126) | 1.98835761 |
| 87 | Clubbing of toes (HP:0100760) | 1.98222346 |
| 88 | Bladder carcinoma (HP:0002862) | 1.98181015 |
| 89 | Bladder neoplasm (HP:0009725) | 1.98181015 |
| 90 | Short 4th metacarpal (HP:0010044) | 1.97280295 |
| 91 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.97280295 |
| 92 | Narrow palate (HP:0000189) | 1.97279203 |
| 93 | Hypoplastic labia majora (HP:0000059) | 1.96702302 |
| 94 | Colitis (HP:0002583) | 1.96461710 |
| 95 | Thyroiditis (HP:0100646) | 1.96051568 |
| 96 | Abnormality of the endocardium (HP:0004306) | 1.95148809 |
| 97 | Malnutrition (HP:0004395) | 1.94740883 |
| 98 | Papillary thyroid carcinoma (HP:0002895) | 1.94673947 |
| 99 | Heterotopia (HP:0002282) | 1.94586991 |
| 100 | Periodontitis (HP:0000704) | 1.94206022 |
| 101 | Menstrual irregularities (HP:0000858) | 1.92693540 |
| 102 | Chronic hepatic failure (HP:0100626) | 1.92486924 |
| 103 | Long clavicles (HP:0000890) | 1.92478229 |
| 104 | Urethral obstruction (HP:0000796) | 1.91880259 |
| 105 | Hypoplasia of the maxilla (HP:0000327) | 1.90447521 |
| 106 | Acute hepatic failure (HP:0006554) | 1.90050012 |
| 107 | Right ventricular cardiomyopathy (HP:0011663) | 1.89554038 |
| 108 | Cheilitis (HP:0100825) | 1.88187661 |
| 109 | Anorexia (HP:0002039) | 1.86936961 |
| 110 | Recurrent bacterial skin infections (HP:0005406) | 1.86031238 |
| 111 | Hypoplasia of the thymus (HP:0000778) | 1.84784221 |
| 112 | Arterial thrombosis (HP:0004420) | 1.83197296 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.81969187 |
| 114 | Myocardial infarction (HP:0001658) | 1.81843257 |
| 115 | Menorrhagia (HP:0000132) | 1.81681992 |
| 116 | Recurrent abscess formation (HP:0002722) | 1.81477267 |
| 117 | Hypoplastic ischia (HP:0003175) | 1.79817225 |
| 118 | Recurrent fungal infections (HP:0002841) | 1.79725027 |
| 119 | Abnormality of the labia majora (HP:0012881) | 1.78812112 |
| 120 | Abnormality of T cells (HP:0002843) | 1.78577224 |
| 121 | Meckel diverticulum (HP:0002245) | 1.76990480 |
| 122 | Fatigue (HP:0012378) | 1.76905198 |
| 123 | Macroorchidism (HP:0000053) | 1.76676996 |
| 124 | Leukocytosis (HP:0001974) | 1.75424213 |
| 125 | Chronic diarrhea (HP:0002028) | 1.75384848 |
| 126 | Tubulointerstitial nephritis (HP:0001970) | 1.74834694 |
| 127 | Thickened calvaria (HP:0002684) | 1.74716268 |
| 128 | Germ cell neoplasia (HP:0100728) | 1.74581028 |
| 129 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.74496176 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74167880 |
| 131 | Anal stenosis (HP:0002025) | 1.73961015 |
| 132 | Papilledema (HP:0001085) | 1.73044703 |
| 133 | Aplasia cutis congenita (HP:0001057) | 1.72563769 |
| 134 | Inappropriate behavior (HP:0000719) | 1.72307896 |
| 135 | Glomerulopathy (HP:0100820) | 1.71967406 |
| 136 | Mitral stenosis (HP:0001718) | 1.71654982 |
| 137 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.71470340 |
| 138 | Abnormality of the incisor (HP:0000676) | 1.71367528 |
| 139 | Gingivitis (HP:0000230) | 1.70342091 |
| 140 | Disinhibition (HP:0000734) | 1.70277198 |
| 141 | Absent speech (HP:0001344) | 1.70059990 |
| 142 | Osteomalacia (HP:0002749) | 1.69866794 |
| 143 | Autoimmune hemolytic anemia (HP:0001890) | 1.68760145 |
| 144 | Abnormality of the renal collecting system (HP:0004742) | 1.68461185 |
| 145 | Acanthocytosis (HP:0001927) | 1.68311618 |
| 146 | Myelodysplasia (HP:0002863) | 1.67683180 |
| 147 | Subacute progressive viral hepatitis (HP:0006572) | 1.66733201 |
| 148 | Abnormality of the renal cortex (HP:0011035) | 1.66321984 |
| 149 | Submucous cleft hard palate (HP:0000176) | 1.65875749 |
| 150 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.65331415 |
| 151 | Abnormality of the frontal sinuses (HP:0002687) | 1.64483939 |
| 152 | Hematochezia (HP:0002573) | 1.64330218 |
| 153 | Smooth philtrum (HP:0000319) | 1.63404200 |
| 154 | Recurrent viral infections (HP:0004429) | 1.63357394 |
| 155 | Distal lower limb amyotrophy (HP:0008944) | 1.61525431 |
| 156 | Myositis (HP:0100614) | 1.61375902 |
| 157 | Keratoconjunctivitis sicca (HP:0001097) | 1.61295040 |
| 158 | Abnormality of the ileum (HP:0001549) | 1.60699623 |
| 159 | Abnormality of the columella (HP:0009929) | 1.60426399 |
| 160 | Hypochromic microcytic anemia (HP:0004840) | 1.60371914 |
| 161 | Abnormal hair whorl (HP:0010721) | 1.59979379 |
| 162 | Tented upper lip vermilion (HP:0010804) | 1.58902626 |
| 163 | Increased number of teeth (HP:0011069) | 1.57490748 |
| 164 | Pulmonary artery stenosis (HP:0004415) | 1.57462946 |
| 165 | Dislocated radial head (HP:0003083) | 1.56973167 |
| 166 | Prominent nose (HP:0000448) | 1.55467674 |
| 167 | Microvesicular hepatic steatosis (HP:0001414) | 1.55325820 |
| 168 | Progressive hearing impairment (HP:0001730) | 1.54694671 |
| 169 | Widely spaced teeth (HP:0000687) | 1.53867354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.74714807 |
| 2 | FRK | 3.09099592 |
| 3 | BRD4 | 2.97706175 |
| 4 | BLK | 2.95596350 |
| 5 | CDK12 | 2.90597878 |
| 6 | LATS1 | 2.67275353 |
| 7 | MAP3K2 | 2.50615816 |
| 8 | FGR | 2.16786536 |
| 9 | MAP3K14 | 2.13153140 |
| 10 | MAP2K3 | 2.12879782 |
| 11 | EPHA3 | 2.11879305 |
| 12 | TXK | 2.03614250 |
| 13 | SGK2 | 2.02269925 |
| 14 | NUAK1 | 1.95487565 |
| 15 | FGFR3 | 1.86343579 |
| 16 | MST4 | 1.84561550 |
| 17 | INSRR | 1.80047862 |
| 18 | JAK3 | 1.78480297 |
| 19 | EIF2AK2 | 1.68898564 |
| 20 | ERBB3 | 1.68101833 |
| 21 | TRPM7 | 1.67593204 |
| 22 | IRAK3 | 1.63171366 |
| 23 | BMPR1B | 1.61681501 |
| 24 | IRAK4 | 1.61388788 |
| 25 | STK3 | 1.61350845 |
| 26 | YES1 | 1.59168423 |
| 27 | NEK9 | 1.58485806 |
| 28 | JAK1 | 1.57062386 |
| 29 | CAMK1D | 1.56978655 |
| 30 | GRK6 | 1.53292347 |
| 31 | PRPF4B | 1.52160065 |
| 32 | CDK3 | 1.50249997 |
| 33 | KSR2 | 1.47638068 |
| 34 | SGK3 | 1.46203793 |
| 35 | ACVR1B | 1.45984973 |
| 36 | MAP4K1 | 1.40396554 |
| 37 | TAOK3 | 1.37406310 |
| 38 | MAP3K3 | 1.36416889 |
| 39 | MAP3K1 | 1.36255843 |
| 40 | IRAK2 | 1.34776086 |
| 41 | ZAP70 | 1.30409929 |
| 42 | CHUK | 1.30341337 |
| 43 | ATR | 1.29523614 |
| 44 | SRPK1 | 1.29428877 |
| 45 | BTK | 1.27176490 |
| 46 | JAK2 | 1.26003903 |
| 47 | STK4 | 1.22679947 |
| 48 | TEC | 1.21473327 |
| 49 | CAMK1G | 1.18787221 |
| 50 | PLK4 | 1.16790667 |
| 51 | RIPK1 | 1.16619694 |
| 52 | KIT | 1.15742149 |
| 53 | FGFR4 | 1.13512826 |
| 54 | PKN2 | 1.12550270 |
| 55 | CDK9 | 1.12514640 |
| 56 | TRIB3 | 1.10201787 |
| 57 | EPHB1 | 1.08031028 |
| 58 | IKBKE | 1.07989647 |
| 59 | KSR1 | 1.06771964 |
| 60 | FGFR2 | 1.06716846 |
| 61 | FES | 1.04090672 |
| 62 | TYK2 | 1.03995628 |
| 63 | CSF1R | 1.03436727 |
| 64 | CDK6 | 1.03067900 |
| 65 | SIK2 | 1.02770971 |
| 66 | TTN | 1.01279163 |
| 67 | RPS6KA4 | 1.00930920 |
| 68 | SYK | 0.99835616 |
| 69 | SIK3 | 0.96467912 |
| 70 | LRRK2 | 0.96006581 |
| 71 | STK10 | 0.94092012 |
| 72 | WNK1 | 0.92440721 |
| 73 | PIK3CA | 0.92231278 |
| 74 | MAP3K12 | 0.90338157 |
| 75 | MAP3K13 | 0.89954829 |
| 76 | RET | 0.89728442 |
| 77 | OXSR1 | 0.88823729 |
| 78 | PDPK1 | 0.88663444 |
| 79 | TAOK1 | 0.86304672 |
| 80 | ERN1 | 0.85544805 |
| 81 | STK39 | 0.85178286 |
| 82 | AKT3 | 0.84513824 |
| 83 | ATM | 0.83535981 |
| 84 | NEK2 | 0.83387002 |
| 85 | TGFBR2 | 0.82254408 |
| 86 | PDK1 | 0.81953024 |
| 87 | STK38L | 0.80446832 |
| 88 | TAF1 | 0.80211850 |
| 89 | PIM1 | 0.79320864 |
| 90 | LYN | 0.79062933 |
| 91 | ITK | 0.78524547 |
| 92 | MARK3 | 0.78290478 |
| 93 | CASK | 0.77548377 |
| 94 | PTK6 | 0.75292179 |
| 95 | IKBKB | 0.74674682 |
| 96 | PRKAA2 | 0.74195063 |
| 97 | SGK223 | 0.73864462 |
| 98 | SGK494 | 0.73864462 |
| 99 | MELK | 0.73599341 |
| 100 | MAP3K5 | 0.73412711 |
| 101 | TNK2 | 0.73198789 |
| 102 | IRAK1 | 0.72534975 |
| 103 | RPS6KB1 | 0.71687757 |
| 104 | RPS6KB2 | 0.71364823 |
| 105 | SGK1 | 0.71310921 |
| 106 | DMPK | 0.71142935 |
| 107 | MAP3K6 | 0.70620520 |
| 108 | CHEK2 | 0.68999288 |
| 109 | EIF2AK3 | 0.68692621 |
| 110 | CDC7 | 0.68141550 |
| 111 | MATK | 0.66009778 |
| 112 | PTK2B | 0.65577961 |
| 113 | RPS6KA5 | 0.63561962 |
| 114 | VRK1 | 0.61567527 |
| 115 | TTK | 0.61315095 |
| 116 | HCK | 0.59787020 |
| 117 | MKNK2 | 0.59058256 |
| 118 | PIK3CG | 0.58184349 |
| 119 | RAF1 | 0.57719718 |
| 120 | BMPR2 | 0.57148376 |
| 121 | PRKAA1 | 0.55868723 |
| 122 | SCYL2 | 0.55823284 |
| 123 | STK38 | 0.54403166 |
| 124 | PLK3 | 0.54376434 |
| 125 | PDGFRB | 0.54193671 |
| 126 | MAPK7 | 0.53078470 |
| 127 | FER | 0.53048832 |
| 128 | MARK2 | 0.50888756 |
| 129 | TBK1 | 0.50679910 |
| 130 | FLT3 | 0.50439978 |
| 131 | CSK | 0.49319222 |
| 132 | AURKB | 0.47629766 |
| 133 | CDK8 | 0.46809614 |
| 134 | AKT1 | 0.45373478 |
| 135 | STK24 | 0.45143569 |
| 136 | IGF1R | 0.44802071 |
| 137 | TAOK2 | 0.43656248 |
| 138 | NEK6 | 0.43631773 |
| 139 | HIPK2 | 0.43472017 |
| 140 | MAPK13 | 0.41048165 |
| 141 | MAPK14 | 0.39380313 |
| 142 | LCK | 0.38146311 |
| 143 | RPS6KA2 | 0.38118002 |
| 144 | PRKCQ | 0.35793718 |
| 145 | PRKCE | 0.35729787 |
| 146 | RIPK4 | 0.35587969 |
| 147 | SIK1 | 0.35223768 |
| 148 | NLK | 0.34704730 |
| 149 | MKNK1 | 0.34188055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12185843 |
| 2 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.11239324 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.10532155 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80094122 |
| 5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.77781864 |
| 6 | Measles_Homo sapiens_hsa05162 | 1.70794977 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 1.58013442 |
| 8 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.56197141 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 1.55521506 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51422357 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47198661 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44618782 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.43601476 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43570845 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 1.39812119 |
| 16 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.39578602 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37431486 |
| 18 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.37279127 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36620347 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36610951 |
| 21 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.34507468 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34174722 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34067299 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.33469212 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29315935 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25491504 |
| 27 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20758761 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18750877 |
| 29 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.16273871 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.15958943 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15194313 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15051881 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13367999 |
| 34 | Prostate cancer_Homo sapiens_hsa05215 | 1.13259844 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11858479 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10793023 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10400505 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08648245 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07834661 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07182963 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.06693750 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05179688 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.04258180 |
| 44 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03946444 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03453829 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.03123127 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02234551 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 1.00400651 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99628533 |
| 50 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98082849 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95969963 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94704312 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.93848123 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 0.93396336 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.92698679 |
| 56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92316151 |
| 57 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92259074 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.91208717 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.90395081 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.90286672 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89138418 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.88753256 |
| 63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88751376 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88468949 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.87346307 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85806209 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85433368 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84373093 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83801364 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.82995477 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82945292 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82665681 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82242717 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81019079 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80916422 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80832391 |
| 77 | Melanoma_Homo sapiens_hsa05218 | 0.80788004 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79218289 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.78421429 |
| 80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77921120 |
| 81 | Hepatitis C_Homo sapiens_hsa05160 | 0.77458426 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76450249 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76101367 |
| 84 | Focal adhesion_Homo sapiens_hsa04510 | 0.75532900 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75447175 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.74723876 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.73375612 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73224641 |
| 89 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72127580 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71714040 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71458483 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71067400 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70874353 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.70129320 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70008349 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.69577588 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68603218 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.67529635 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.66430767 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65855608 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.65530583 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65180109 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64946656 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64766622 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63947799 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.63598867 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63535842 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.63514014 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63172612 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62284650 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.61594499 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59111044 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58671431 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58603535 |
| 115 | Base excision repair_Homo sapiens_hsa03410 | 0.58225469 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57213317 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56886622 |
| 118 | Salmonella infection_Homo sapiens_hsa05132 | 0.56263500 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56233469 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56094200 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.55751988 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55711658 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54803459 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54385742 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54145053 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54125275 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51556889 |
| 128 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51098811 |
| 129 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50012982 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49532607 |
| 131 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.48272248 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47766904 |
| 133 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46165692 |

